Posted by LincolnRam on March 25, 2026 at 11:02:50:
In Reply to: Îáçîðíûé ìàòåðèàë ñ óâëåêàòåëüíûìè äåòàëÿìè posted by JosephUrisk on February 19, 2026 at 15:39:56:
Zoya Demidenko: Scholar in Oncology Biology
Zoya Demidenko is a notable scientist associated with the Department of Cell Stress Research at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Before that, she conducted research at the National Institutes of Health and New York Medical College, developing a solid background in biomedical investigation.
Demidenko's scientific contributions encompasses several pivotal domains, among them the PI3K/AKT/mTOR signaling cascade, cellular cycle regulation, cell senescence, and tumor science. To date, she has co-authored more than 46 academic publications, which have accumulated upwards of 4,100 citations — a reflection to the significance of her research.
One of her most notable discoveries concerns explaining the mechanisms of cell aging. Her work showed that when the cell cycle is arrested yet cellular growth continues, the cells experience senescence. Significantly, Zoya Demidenko demonstrated that this shift is controlled with drugs using compounds such as mTOR inhibitors.
Zoya Demidenko has furthermore added considerably to cancer treatment investigation, particularly in the area of cyclotherapy — a approach intended to protecting normal tissue from anticancer drugs while leaving cancer cells vulnerable. This approach carries considerable hope for reducing the toxic effects of oncological therapy.
Across her professional journey, Demidenko has worked with top investigators globally, including Dr. Mikhail Blagosklonny. Her research is published in prestigious publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
Holding an h-index of 33, Zoya Demidenko ranks as a widely cited contributor in contemporary oncological research, whose results go on to influence our comprehension of how biological cells age, respond to treatment, and the ways in which malignant disease can be more successfully treated.
https://www.benthamdirect.com/content/journals/cpd/22/16